Central Neuropathic Pain Development Modulation Using Coffee Extract Major Polyphenolic Compounds in Spinal-Cord-Injured Female Mice.

4-O-caffeoylquinic acid chlorogenic acid coffee extract gliosis neochlorogenic acid neuropathic pain polyphenols spinal cord injury

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
04 Nov 2022
Historique:
received: 27 09 2022
revised: 24 10 2022
accepted: 03 11 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

It was recently shown that coffee polyphenolic extract exerts preventive effects on central neuropathic pain development, but it is unknown whether its beneficial effects are associated with only one of its major polyphenolic compounds or if the whole extract is needed to exert such effects. The main objective of this study was to determine whether the separate administration of major polyphenols from coffee extract exerts preventive effects on the development of central neuropathic pain in mice compared with the effects of the whole coffee extract. Thus, spinal-cord-injured female ICR-CD1 mice were daily treated with either coffee extract or its major polyphenolic compounds during the first week, and reflexive and nonreflexive pain responses were evaluated within the acute phase of spinal cord injury. In addition, the injury-induced gliosis and dorsal horn sprouting were evaluated with immunohistochemistry. The results showed that the coffee extract prevented spinal cord injury-induced neuropathic pain, whereas its major polyphenolic compounds resulted in reflexive pain response attenuation. Both preventive and attenuation effects were associated with gliosis and afferent fiber sprouting modulation. Overall, the results suggested that coffee extract effects may be associated with potential synergistic mechanisms exerted by its major polyphenolic compounds and not by the sole effect of only one of them.

Identifiants

pubmed: 36358318
pii: biology11111617
doi: 10.3390/biology11111617
pmc: PMC9687351
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : La Marató de TV3 Foundation
ID : 201705.30.31
Organisme : Vice-Chancellorship of Research of the University of Girona
ID : MPCUdG2016/087

Références

J Nat Med. 2013 Oct;67(4):698-704
pubmed: 23203628
Genes Nutr. 2012 Apr;7(2):99-109
pubmed: 22012276
J Pain. 2009 Jun;10(6):619-27
pubmed: 19398383
J Neuroimmunol. 2019 Jul 15;332:37-48
pubmed: 30933849
J Neurosci. 2011 Apr 27;31(17):6277-88
pubmed: 21525267
Molecules. 2020 Mar 18;25(6):
pubmed: 32197466
Neural Plast. 2017;2017:2480689
pubmed: 28951789
Sci Rep. 2022 Sep 02;12(1):14980
pubmed: 36056079
Front Pharmacol. 2019 Mar 22;10:222
pubmed: 30967775
Biomed Pharmacother. 2018 Jan;97:67-74
pubmed: 29080460
Front Cell Neurosci. 2016 Apr 13;10:98
pubmed: 27147970
Pharmaceutics. 2021 Feb 11;13(2):
pubmed: 33670393
J Med Food. 2014 Jun;17(6):730-2
pubmed: 24611441
Neurosci Lett. 2012 Feb 29;510(2):138-42
pubmed: 22281445
Neuropharmacology. 2014 Feb;77:100-19
pubmed: 24071567
Eur J Pain. 2017 Jan;21(1):29-44
pubmed: 27341614
Int Immunopharmacol. 2018 Jan;54:125-130
pubmed: 29128856
J Neurosci. 1998 Apr 15;18(8):3059-72
pubmed: 9526023
Inflammopharmacology. 2019 Feb;27(1):189-197
pubmed: 30547263
Int Immunopharmacol. 2022 Jun;107:108706
pubmed: 35313270
Neurochem Res. 2015 Sep;40(9):1792-8
pubmed: 26152332
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18789628
pubmed: 30051721
Glia. 1998 Jun;23(2):120-9
pubmed: 9600380
Oxid Med Cell Longev. 2022 Jan 7;2022:8100195
pubmed: 35035667
J Neuroinflammation. 2012 Jul 23;9:178
pubmed: 22824323
J Agric Food Chem. 2008 Feb 13;56(3):705-12
pubmed: 18211026
J Pharmacol Exp Ther. 2008 Jul;326(1):196-208
pubmed: 18417733
Curr Psychiatry Rep. 2013 Dec;15(12):421
pubmed: 24214740
Eur J Pain. 2016 Mar;20(3):341-52
pubmed: 25913854
Environ Toxicol Pharmacol. 2018 Sep;62:1-10
pubmed: 29908432
Mol Cell Neurosci. 1996;8(4):211-20
pubmed: 9000437
Cell. 2009 Oct 16;139(2):267-84
pubmed: 19837031
Eur J Pharmacol. 2014 Jan 15;723:459-64
pubmed: 24184666
Pain. 1983 Jun;16(2):109-110
pubmed: 6877845
Neurosci Res. 2020 Aug;157:34-43
pubmed: 31348996
Biotechnol Adv. 2015 Dec;33(8):1582-1614
pubmed: 26281720
Exp Neurol. 2014 May;255:38-48
pubmed: 24560714
Nutrients. 2015 Dec 25;8(1):
pubmed: 26712785
Free Radic Biol Med. 2008 Aug 1;45(3):295-305
pubmed: 18457678
Neuroscience. 1998 Jul;85(2):443-58
pubmed: 9622243
J Neurochem. 2014 Nov;131(4):413-7
pubmed: 25051888
Pain. 1988 Jan;32(1):77-88
pubmed: 3340425
J Neuroinflammation. 2019 Apr 10;16(1):78
pubmed: 30971286
J Food Drug Anal. 2018 Jul;26(3):985-993
pubmed: 29976416
J Neurosci Res. 2005 Oct 1;82(1):138-48
pubmed: 16075466
J Sep Sci. 2017 Nov;40(22):4357-4365
pubmed: 28929588
Prog Neurobiol. 1996 Jun;49(2):99-123
pubmed: 8844822
Restor Neurol Neurosci. 2018;36(5):659-668
pubmed: 30040768
Vet Rec. 1985 Apr 20;116(16):431-6
pubmed: 3923690
Pain. 2017 Mar;158(3):371-376
pubmed: 27941498
Curr Neuropharmacol. 2020;18(3):216-228
pubmed: 31631820
Comput Math Methods Med. 2022 May 18;2022:6282167
pubmed: 35633920
Brain. 2004 Jun;127(Pt 6):1403-14
pubmed: 15069022
Front Physiol. 2020 Aug 19;11:1016
pubmed: 32973552
J Neurotrauma. 2006 May;23(5):635-59
pubmed: 16689667
Nat Chem Biol. 2007 Jul;3(7):360-6
pubmed: 17576417
Exp Neurol. 2000 Jul;164(1):53-9
pubmed: 10877915
Expert Rev Neurother. 2022 Jul;22(7):595-622
pubmed: 35866187
Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36
pubmed: 596982
Curr Drug Targets. 2017;18(2):160-173
pubmed: 27231108
Indian J Med Res. 2010 May;131:682-91
pubmed: 20516541
Mol Pain. 2012 Sep 10;8:64
pubmed: 22963197
Brain Res Bull. 2012 Aug 1;88(5):487-94
pubmed: 22580132
Annu Rev Pharmacol Toxicol. 1980;20:441-62
pubmed: 7387124
J Agric Food Chem. 2010 Apr 14;58(7):3950-6
pubmed: 20128604
Life Sci. 2015 Apr 15;127:12-8
pubmed: 25744394
Sci Rep. 2018 Mar 1;8(1):3873
pubmed: 29497125
Eur J Pharmacol. 2013 Sep 15;716(1-3):106-19
pubmed: 23500198
J Neurotrauma. 2018 Sep 15;35(18):2222-2238
pubmed: 29706124
Sci Rep. 2022 Jun 12;12(1):9719
pubmed: 35691979
J Neuroimmunol. 2013 Jan 15;254(1-2):161-4
pubmed: 22944319
Nat Rev Drug Discov. 2021 Mar;20(3):200-216
pubmed: 33510482
Rev Neurol (Paris). 2019 Jan - Feb;175(1-2):46-50
pubmed: 30318260
Pharmacol Res. 2020 Dec;162:105280
pubmed: 33161139
Anticancer Res. 2022 Jul;42(7):3389-3402
pubmed: 35790282

Auteurs

Roger Soler-Martínez (R)

Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA), Department of Medical Sciences, University of Girona, E-17003 Girona, Catalonia, Spain.

Meritxell Deulofeu (M)

Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA), Department of Medical Sciences, University of Girona, E-17003 Girona, Catalonia, Spain.

Anna Bagó-Mas (A)

Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA), Department of Medical Sciences, University of Girona, E-17003 Girona, Catalonia, Spain.

Petr Dubový (P)

Department of Anatomy, Division of Neuroanatomy, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Enrique Verdú (E)

Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA), Department of Medical Sciences, University of Girona, E-17003 Girona, Catalonia, Spain.

Núria Fiol (N)

Department of Chemical Engineering, Agriculture and Food Technology, Polytechnic School, University of Girona, E-17003 Girona, Catalonia, Spain.

Pere Boadas-Vaello (P)

Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA), Department of Medical Sciences, University of Girona, E-17003 Girona, Catalonia, Spain.

Classifications MeSH